| HILGX | VMVAX | HILGX / VMVAX | |
| Total Expense Ratio | 1.00 | 0.07 | 1,429% |
| Annual Report Gross Expense Ratio | 1.00 | 0.07 | 1,429% |
| Fund Existence | 17 years | 14 years | - |
| Gain YTD | 3.989 | 11.046 | 36% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 3000 | 8,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 135M | 32.6B | 0% |
| Annual Yield % from dividends | 1.12 | 2.14 | 52% |
| Returns for 1 year | 2.73 | 9.63 | 28% |
| Returns for 3 years | 22.71 | 32.97 | 69% |
| Returns for 5 years | 8.45 | 54.00 | 16% |
| Returns for 10 years | 29.61 | 109.34 | 27% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EEMFX | 10.11 | 0.06 | +0.60% |
| MFS Emerging Markets Equity Research R3 | |||
| TRERX | 16.61 | 0.04 | +0.24% |
| Nuveen International Eq Retire | |||
| AMGOX | 24.24 | -0.06 | -0.25% |
| Alger Mid Cap Growth I-2 | |||
| RLITX | 13.22 | -0.04 | -0.30% |
| Lazard International Strategic Eq R6 | |||
| NSNRX | 51.19 | -0.39 | -0.76% |
| Neuberger Small Cap Growth R3 | |||